Skip to content
No results
  • Home
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • About Us
  • Contact Us
The Pharma Data
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
Hello Heart
  • Press Releases

Hello Heart Launches Smart Pill Box to Transform Medication Adherence

  • The Pharma Data
  • April 8, 2025

Hello Heart Launches Smart Pill Box to Transform Medication Adherence In a significant step forward for digital heart health management, Hello Heart, the leading digital platform for preventive heart care,…

Read MoreHello Heart Launches Smart Pill Box to Transform Medication Adherence
Approves
  • Regulatory

EU Approves Expanded Use of KAFTRIO for Cystic Fibrosis

  • The Pharma Data
  • April 8, 2025

EU Approves Expanded Use of KAFTRIO for Cystic Fibrosis Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced a significant milestone in the ongoing fight against cystic fibrosis (CF). The European Commission…

Read MoreEU Approves Expanded Use of KAFTRIO for Cystic Fibrosis
Prollenium
  • Press Releases

Prollenium Announces Leadership Transition

  • The Pharma Data
  • April 7, 2025

Prollenium Announces Leadership Transition Prollenium Medical Technologies (“Prollenium” or “the Company”), a leading innovator in the aesthetic medical space, has announced a significant leadership change as Ario Khoshbin, its Founder…

Read MoreProllenium Announces Leadership Transition
Sentynl
  • Regulatory

Sentynl Unveils First Full Clinical Data Supporting NULIBRY® for MoCD Type A

  • The Pharma Data
  • April 5, 2025

Sentynl Unveils First Full Clinical Data Supporting NULIBRY® for MoCD Type A Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company and a wholly owned subsidiary of Zydus Lifesciences Ltd. (“Zydus…

Read MoreSentynl Unveils First Full Clinical Data Supporting NULIBRY® for MoCD Type A
Prollenium
  • Press Releases

Prollenium Unveils New Leadership Structure

  • The Pharma Data
  • April 5, 2025

Prollenium Unveils New Leadership Structure In a significant leadership transition aimed at fostering continued growth and innovation, Prollenium Medical Technologies (“Prollenium” or “the Company”) has announced that Ario Khoshbin, the…

Read MoreProllenium Unveils New Leadership Structure
RenovoRx
  • News

RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th

  • The Pharma Data
  • April 5, 2025

RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company focused on the…

Read MoreRenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th
Hologic
  • Press Releases

Hologic Appoints Wayde McMillan to Board of Directors

  • The Pharma Data
  • April 5, 2025

Hologic Appoints Wayde McMillan to Board of Directors Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment,…

Read MoreHologic Appoints Wayde McMillan to Board of Directors
Bayer
  • Press Releases

Bayer Announces Petition Filing to U.S. Supreme Court for Review in Durnell Roundup Case

  • The Pharma Data
  • April 5, 2025

Bayer Announces Petition Filing to U.S. Supreme Court for Review in Durnell Roundup Case On April 4, 2025, Bayer AG, through its indirect subsidiary Monsanto, officially filed a petition for…

Read MoreBayer Announces Petition Filing to U.S. Supreme Court for Review in Durnell Roundup Case
WHO
  • News

WHO brings countries together to test collective pandemic response

  • The Pharma Data
  • April 5, 2025

WHO brings countries together to test collective pandemic response In a significant step toward improving global pandemic preparedness, the World Health Organization (WHO) recently led a groundbreaking two-day international simulation…

Read MoreWHO brings countries together to test collective pandemic response
FDA
  • Regulatory

FDA Issues Complete Response Letter to Aldeyra for Reproxalap Dry Eye NDA

  • The Pharma Data
  • April 4, 2025

FDA Issues Complete Response Letter to Aldeyra for Reproxalap Dry Eye NDA Aldeyra Therapeutics, Inc.a biotechnology company committed to the development of innovative therapies targeting immune-mediated and metabolic diseases, announced…

Read MoreFDA Issues Complete Response Letter to Aldeyra for Reproxalap Dry Eye NDA
Akamis Bio
  • Research

Akamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A

  • The Pharma Data
  • April 4, 2025

Akamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A Akamis Bio, a clinical-stage biotechnology company at the forefront of immuno-oncology innovation, announced a major milestone in…

Read MoreAkamis Bio Doses First Patient in Phase 1b Rectal Cancer Trial of NG-350A
Xaira
  • Press Releases

Xaira Therapeutics Appoints Bo Wang as SVP and Head of Biomedical AI

  • The Pharma Data
  • April 4, 2025

Xaira Therapeutics Appoints Bo Wang as SVP and Head of Biomedical AI In a strategic move that underscores its deepening commitment to revolutionizing drug discovery through artificial intelligence, Xaira Therapeutics…

Read MoreXaira Therapeutics Appoints Bo Wang as SVP and Head of Biomedical AI
PrevNext

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • EmeraNova™ Strengthens Innovation Leadership with Launch of New Accelerator ProgramNovember 5, 2026
  • Global Healthy Living Foundation Highlights Advances in Myositis and Polymyalgia Rheumatica Research at ACR Convergence 2026November 5, 2026
  • Polaris Rx Chosen by Bristol Myers Squibb to Distribute ZENBEXUS™, the First FDA-Approved CELMoD Treatment for Multiple MyelomaNovember 5, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.